Lipid lowering: PCSK9 inhibitors - new kids on the block target their breakthrough.
- Mohaupt M Department of Nephrology, Hypertension and Clinical Pharmacology; Department of Clinical Research; both University of Bern, Switzerland.
- 2016-08-04
Published in:
- Swiss medical weekly. - 2016
Anticholesteremic Agents
Apolipoproteins B
Cholesterol, LDL
Dyslipidemias
Humans
Hyperlipoproteinemia Type II
Proprotein Convertase 9
- Language
-
- English
- Open access status
- gold
- Identifiers
-
- DOI 10.4414/smw.2016.14345
- PMID 27487027
- Persistent URL
- https://sonar.ch/global/documents/278580
Export to…
Statistics
Document views: 57
File downloads:
- Full-text: 0